Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Mintel, the experts in what consumers want and why, has today announced four key trends that will shape the global food and drink industry in the years ahead. In 2025 and beyond, expect to see GLP-1 ...

IN a world with soaring obesity rates, fat jabs have arrived and taken the world of the rich and beautiful by storm. The injections have allegedly helped celebrities like Elon Musk, Sharon ...

The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and ...

The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...

The latest plan to tackle obesity in the UK could also help to get people back into work, but what are the risks?

Studies show that people with obesity are more likely to find that ill health affects their productivity and attendance at work.

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...

ROACH: I am 5 feet, 1 inch tall, weigh 200 pounds, and have found it next to impossible to lose weight, even though I'm active. I swim, walk, or do yoga almost every day. I avoid most processed foods ...

Rapper Fat Joe recently shared how he’s been using the Type 2 diabetes medication Ozempic to maintain his 200-pound weight ...

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

Taking Ozempic can cause nausea, diarrhea, vomiting, and potential muscle loss. Here, doctors share common and uncommon side ...